Bulletin of Experimental Biology and Medicine

, Volume 144, Issue 2, pp 203–206 | Cite as

Oxidative status and citrate concentration in rat tissues during experimental hyperthyroidism and melatonin treatment

  • S. S. Popov
  • A. N. Pashkov
  • T. N. Popova
  • V. I. Zoloedov
  • A. V. Semenikhina
  • T. I. Rakhmanova
Article

Abstract

Biochemiluminescence increased, while aconitate hydratase activity and citrate accumulation in tissues of the liver and heart and blood decreased in rats with experimental hyperthyroidism. These changes reflect activation of free radical oxidation, damage to enzyme molecules with reactive oxygen species, and impaired utilization of citrate under pathological conditions. Melatonin treatment during hyperthyroidism normalized aconitate hydratase activity and citrate concentration. Biochemiluminescence study showed that the effect of melatonin is related to antioxidant activity of this hormone, inhibition of free radical oxidation, and suppression of reactive oxygen species generation.

Key Words

experimental hyperthyroidism melatonin oxidative status 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V. A. Baraboi, Ukr. Biokhim. Zh., 72, No. 3, 5–11 (2000).PubMedGoogle Scholar
  2. 2.
    I. F. Belenichev, Yu. I. Gubskii, E. L. Levitskii, et al., Suchasni Probl. Toksikol. (Sovrem. Probl. Toksikol.) [Electronic Resource], 2003, No. 2, http://www.medved.kiev.ua/arhiv_mg/st_2003/03_2_2.htm.
  3. 3.
    I. I. Dedov, G. A. Mel’nichenko, and V. V. Fadeev, Endocrinology [in Russian], Moscow (2000).Google Scholar
  4. 4.
    F. I. Komarov, S. I. Rapoport, N. K. Malinovskaya, and V. N. Anisimov, Melatonin under Normal and Pathological Conditions [in Russian], Moscow (2004).Google Scholar
  5. 5.
    L. V. Medvedeva, T. N. Popova, V. G. Artyukhov, et al., Byull. Eksp. Biol. Med., 134, No. 8, 151–156 (2002).Google Scholar
  6. 6.
    A. N. Pashkov, S. S. Popov, A. V. Semenikhina, and T. I. Rakhmanova, Ibid., 139, No. 5, 520–525 (2005).CrossRefGoogle Scholar
  7. 7.
    R. F. Castilho, A. J. Kowaltowski, and A. E. Vercesi, Arch. Biochem. Biophys., 354, No. 1, 151–157 (1998).PubMedCrossRefGoogle Scholar
  8. 8.
    V. Fernandez, K. Simizu, S. B. Barros, et al., Endocrinology, 129, No. 1, 85–91 (1991).PubMedCrossRefGoogle Scholar
  9. 9.
    P. R. Gardner, I. Raineri, L. B. Epstein, and C. W. White, J. Biol. Chem., 270, No. 22, 13,399–13,405 (1995).Google Scholar
  10. 10.
    I. Rodriguez-Gomez, R. Wangensteen, J. M. Moreno, et al., Am. J. Physiol. Endocrinol. Metab., 288, No. 6, E1252–E1257 (2005).PubMedCrossRefGoogle Scholar
  11. 11.
    V. P. Skulachev, Q. Rev. Biophys., 29, No. 2, 169–202 (1996).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • S. S. Popov
    • 1
  • A. N. Pashkov
    • 1
  • T. N. Popova
    • 2
  • V. I. Zoloedov
    • 1
  • A. V. Semenikhina
    • 2
  • T. I. Rakhmanova
    • 2
  1. 1.N. N. Burdenko Voronezh State Medical AcademyRussia
  2. 2.Voronezh State UniversityRussia

Personalised recommendations